Page last updated: 2024-11-01

omeprazole and Adenocarcinoma Of Kidney

omeprazole has been researched along with Adenocarcinoma Of Kidney in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koop, H1
Koop, I1
Klein, M1
Stumpf, M1
Massarrat, S1
Arnold, R1

Other Studies

1 other study available for omeprazole and Adenocarcinoma Of Kidney

ArticleYear
Irradiation-induced duodenal ulcer disease refractory to ranitidine: healing by omeprazole.
    Journal of clinical gastroenterology, 1989, Volume: 11, Issue:6

    Topics: Aged; Carcinoma, Renal Cell; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Kidney Neopla

1989